Back

Iron-deficiency in the tumor microenvironment reprograms tumor-immune interactions in a sex biased manner

Sahu, A. P.; Hao, Y.; Baker, A.; Palsa, K.; Helmuth, T.; Shenoy, G.; Neely, E. B.; Slagle-Webb, B.; Berens, M. E.; Connor, J.

2026-06-02 cancer biology
10.64898/2026.05.29.728615 bioRxiv
Show abstract

BackgroundGlioblastoma (GBM) is a sex-biased disease characterized by higher incidence and poorer survival in males. These sex differences are primarily driven by metabolic and immune signatures, with iron metabolism playing a major role. While iron is essential for tumor cell proliferation, it is also critical for T cell recruitment and function within the tumor microenvironment (TME). Clinical data indicates that iron deficiency impacts GBM survival in a sex-biased manner; however, the underlying mechanisms remain unexplored. MethodsWe employed a FTH1 heterozygous knockdown mouse model to induce tumor iron deficiency in GBM-bearing mice. TME dynamics were interrogated using flow cytometry and spatial transcriptomics (10X Xenium) to analyze immune infiltration, localization, and ligand-receptor signaling between GBM and immune cells. ResultsFTH1 knockdown resulted in iron deficiency in the GBM TME. Iron deficiency altered the TME dynamics in a sex biased manner. FTH1 knockdown in females caused an anti-inflammatory, cytokine deficient TME which failed to recruit CD4 and CD8 T cells. In males, FTH1 knockdown caused a proinflammatory environment by activating the innate immune response. Additionally, FTH1 knockdown increased the density of TAMs in the immediate surrounding of GBM cells in a sex biased manner. ConclusionThese results demonstrate that tumor iron plays a sex-biased role in immune infiltration and anti-tumor immunity.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Clinical Epigenetics
53 papers in training set
Top 0.1%
23.6%
2
PLOS ONE
4510 papers in training set
Top 16%
10.9%
3
Neuro-Oncology
30 papers in training set
Top 0.1%
10.6%
4
Cancers
200 papers in training set
Top 0.9%
5.1%
50% of probability mass above
5
Neuro-Oncology Advances
24 papers in training set
Top 0.1%
4.5%
6
Scientific Reports
3102 papers in training set
Top 32%
3.8%
7
Frontiers in Oncology
95 papers in training set
Top 1%
3.8%
8
Neoplasia
22 papers in training set
Top 0.1%
3.2%
9
Aging
69 papers in training set
Top 0.9%
2.2%
10
OncoImmunology
22 papers in training set
Top 0.2%
1.4%
11
Acta Neuropathologica Communications
81 papers in training set
Top 0.7%
1.4%
12
International Journal of Cancer
42 papers in training set
Top 0.9%
1.2%
13
BMC Cancer
52 papers in training set
Top 2%
1.0%
14
Epigenetics
43 papers in training set
Top 0.6%
1.0%
15
Cancer Research
116 papers in training set
Top 3%
0.8%
16
Cancer Research Communications
46 papers in training set
Top 1%
0.8%
17
Computers in Biology and Medicine
120 papers in training set
Top 4%
0.8%
18
Redox Biology
64 papers in training set
Top 0.9%
0.8%
19
International Journal of Molecular Sciences
453 papers in training set
Top 15%
0.8%
20
Antibody Therapeutics
16 papers in training set
Top 0.5%
0.8%
21
Frontiers in Physiology
93 papers in training set
Top 6%
0.8%
22
Frontiers in Molecular Biosciences
100 papers in training set
Top 5%
0.8%
23
Molecular Cancer Research
42 papers in training set
Top 0.7%
0.8%
24
Journal of the Neurological Sciences
17 papers in training set
Top 0.8%
0.7%
25
Interface Focus
14 papers in training set
Top 0.4%
0.7%
26
PeerJ
261 papers in training set
Top 18%
0.5%
27
The American Journal of Pathology
31 papers in training set
Top 0.7%
0.5%